Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.
about
Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines.
P2860
Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Development of a therapy again ...... der cancer stem cells vaccine.
@ast
Development of a therapy again ...... der cancer stem cells vaccine.
@en
type
label
Development of a therapy again ...... der cancer stem cells vaccine.
@ast
Development of a therapy again ...... der cancer stem cells vaccine.
@en
prefLabel
Development of a therapy again ...... der cancer stem cells vaccine.
@ast
Development of a therapy again ...... der cancer stem cells vaccine.
@en
P2093
P2860
P1476
Development of a therapy again ...... der cancer stem cells vaccine.
@en
P2093
Cheng-Yong Lei
Qing-Jun Chu
Shi-Yu Pang
Wan-Long Tan
Yong-Tong Zhu
P2860
P2888
P356
10.1186/S13287-015-0211-1
P577
2015-11-14T00:00:00Z
P5875
P6179
1048157512